fbpx

FDA Authorizes Regeneron’s Covid-19 Antibody Cocktail Drug

FDA Authorizes Regeneron’s Covid-19 Antibody Cocktail Drug

Regeneron Pharmaceuticals Inc.’s Covid-19 antibody drug was authorized Saturday by U.S. health regulators, the second cleared this month to treat pati

GM Won’t Take Stake in Nikola
Purdue Pharma Reaches $8.34 Billion Settlement Over Opioid Probes
Biden Labor Department to Focus on Executive Actions If GOP Keeps Senate

Regeneron Pharmaceuticals Inc.’s Covid-19 antibody drug was authorized Saturday by U.S. health regulators, the second cleared this month to treat patients who aren’t hospitalized but are at high risk of developing severe disease.

The Food and Drug Administration cleared the antibody drug cocktail for use treating mild to moderate Covid-19 patients 12 years of age and older, including people older than 65 years.

Regeneron’s…

This post first appeared on wsj.com

Do You Enjoy This Article?
Sign up for our newsletter and receive FREE access to download SuccessDigest Digital Weekly Edition for attainment of your financial freedom in the new digital economy!

Invalid email address
We promise not to spam you. You can unsubscribe at any time.

COMMENTS

WORDPRESS: 0
DISQUS: 0
%d bloggers like this: